BigClassActions.com
Advertisement

GlaxoSmithKline NYSE: GSK



Company: GlaxoSmithKline
Ticker Symbol: NYSE: GSK
Class Period: February 21, 2001, to August 5, 2004
Date Filed: Apr-13-05
Lead Plaintiff Deadline: Jun-13-05
Court: Southern District, NY
Allegations:
A securities class action was commenced on behalf of shareholders who purchased, converted, exchanged or otherwise acquired the common stock and ADRs of GlaxoSmithKline plc (NYSE: GSK) between February 21, 2001, and August 5, 2004, inclusive (the "Class Period").

The case is pending in the United States District Court for the Southern District of New York against defendant GlaxoSmithKline and one or more of its officers and/or directors. The action charges that defendants violated federal securities laws by issuing a series of materially false and misleading statements to the market throughout the Class Period, which statements had the effect of artificially inflating the market price of the Company's securities.

If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.


If you feel you qualify for damages or remedies that might be awarded in this class action please fill in our form on the right to submit your complaint.

Maybe it's your stockbroker

Add Your Comment on This Issue

Please read our comment guidelines before posting.


Note: Your name will be published with your comment.


Your email will only be used if a response is needed.

Request Legal Help